Compounds > tolvaptan
Page last updated: 2024-09-05

tolvaptan and Liver Neoplasms

tolvaptan has been researched along with Liver Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Azumi, M; Honma, T; Imai, M; Ishikawa, T; Iwanaga, A; Kojima, Y; Nozawa, Y; Sano, T; Yoshida, T1
Enomoto, N; Hayakawa, Y; Higuchi, M; Inada, K; Itakura, J; Izumi, N; Kaneko, S; Kirino, S; Komiyama, Y; Kurosaki, M; Maeyashiki, C; Nakanishi, H; Okada, M; Osawa, L; Sekiguchi, S; Takada, H; Takahashi, Y; Takaura, K; Tamaki, N; Tsuchiya, K; Wang, W; Yamashita, K; Yasui, Y1
Goya, T; Kato, M; Kohjima, M; Kotoh, K; Masumoto, A; Miyazaki, M; Motomura, K; Senjyu, T; Tanaka, K; Yada, M1
Hayata, Y; Ito, D; Karasawa, Y; Kawamura, S; Kojima, K; Ohki, T; Seki, M; Tagawa, K; Toda, N; Yamada, T1

Other Studies

4 other study(ies) available for tolvaptan and Liver Neoplasms

ArticleYear
Prediction factors of tolvaptan effectiveness in patients with refractory ascites complicated with hepatocellular carcinoma.
    European journal of gastroenterology & hepatology, 2021, 12-01, Volume: 33, Issue:1S Suppl 1

    Topics: Aged; Ascites; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Male; Prognosis; Retrospective Studies; Tolvaptan; Treatment Outcome

2021
Plasma Renin Activity Predicts Prognosis and Liver Disease-Related Events in Liver Cirrhosis Patients with Ascites Treated by Tolvaptan.
    Digestive diseases (Basel, Switzerland), 2022, Volume: 40, Issue:4

    Topics: Ascites; Carcinoma, Hepatocellular; Humans; Liver Cirrhosis; Liver Neoplasms; Prognosis; Renin; Retrospective Studies; Tolvaptan

2022
Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma.
    World journal of gastroenterology, 2017, Aug-07, Volume: 23, Issue:29

    Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Body Weight; Carcinoma, Hepatocellular; Disease Progression; Diuretics; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Female; Furosemide; Humans; Liver; Liver Failure; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Spironolactone; Tolvaptan; Treatment Outcome

2017
Potential Effectiveness of Tolvaptan to Improve Ascites Unresponsive to Standard Diuretics and Overall Survival in Patients with Decompensated Liver Cirrhosis.
    Clinical drug investigation, 2016, Volume: 36, Issue:10

    Topics: Aged; Ascites; Benzazepines; Carcinoma, Hepatocellular; Diuretics; Female; Humans; Hyponatremia; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Survival Rate; Tolvaptan

2016